文献速递区域麻醉与超声神经外科与老年麻醉

利多卡因在糖尿病神经病变啮齿类模型中的药效学与药代动力学

Pharmacodynamics and Pharmacokinetics of Lidocaine in a Rodent Model of Diabetic Neuropathy.
PubMed 文献 · Anesthesiology · 2018-01-01

研究在25只20周龄Zucker糖尿病肥胖大鼠(经神经生理学证实存在神经病变)及对照大鼠中开展坐骨神经阻滞实验,测定利多卡因体内最低局麻药剂量、神经内浓度及背根神经节钠通道活性。结果显示糖尿病大鼠运动阻滞最低局麻药剂量显著更低(0.9% vs 1.4%),阻滞后60分钟神经内利多卡因更高,且利多卡因抑制钠电流的浓度更低。结论为糖尿病神经病变神经对局麻药敏感性增加且局麻药滞留时间延长,药效学与药代动力学机制共同延长神经阻滞持续时间。

要点

  • 糖尿病神经病变大鼠坐骨神经运动阻滞的利多卡因最低局麻药剂量显著低于对照(0.9% vs 1.4%)。
  • 阻滞后60分钟糖尿病动物神经内利多卡因浓度更高,提示局麻药滞留延长。
  • 神经病变神经元中利多卡因抑制钠电流的浓度更低,提示敏感性增加。

核心结论

  • 在糖尿病神经病变啮齿类模型中,糖尿病神经对局麻药敏感性增加且局麻药在神经内滞留时间延长,药效学与药代动力学机制共同导致神经阻滞持续时间延长。

研究设计与样本

  • 在25只20周龄Zucker糖尿病肥胖大鼠(经神经生理学证实存在神经病变)及对照大鼠中开展一系列坐骨神经阻滞实验。
  • 体内测定利多卡因坐骨神经阻滞的最低局麻药剂量。
  • 给药后至90分钟测定放射性标记利多卡因浓度。
  • 切除背根神经节进行膜片钳测量钠通道活性。

主要发现

  • 体内坐骨神经运动阻滞的利多卡因最低局麻药剂量在糖尿病大鼠(0.9%)显著低于对照大鼠(1.4%)。
  • 神经阻滞后60分钟,糖尿病动物神经内利多卡因浓度更高。
  • 单细胞测量显示,与对照神经元相比,神经病变神经元中利多卡因阻断钠电流的抑制浓度更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical and experimental data show that peripheral nerve blocks last longer in the presence of diabetic neuropathy. This may occur because diabetic nerve fibers are more sensitive to local anesthetics or because the local anesthetic concentration decreases more slowly in the diabetic nerve. The aim of this study was to investigate both hypotheses in a rodent model of neuropathy secondary to type 2 diabetes. METHODS: We performed a series of sciatic nerve block experiments in 25 Zucker Diabetic Fatty rats aged 20 weeks with a neuropathy component confirmed by neurophysiology and control rats. We determined in vivo the minimum local anesthetic dose of lidocaine for sciatic nerve block. To investigate the pharmacokinetic hypothesis, we determined concentrations of radiolabeled (C) lidocaine up to 90 min after administration. Last, dorsal root ganglia were excised for patch clamp measurements of sodium channel activity. RESULTS: First, in vivo minimum local anesthetic dose of lidocaine for sciatic nerve motor block was significantly lower in diabetic (0.9%) as compared to control rats (1.4%). Second, at 60 min after nerve block, intraneural lidocaine was higher in the diabetic animals. Third, single cell measurements showed a lower inhibitory concentration of lidocaine for blocking sodium currents in neuropathic as compared to control neurons. CONCLUSIONS: We demonstrate increased sensitivity of the diabetic neuropathic nerve toward local anesthetics, and prolonged residence time of local anesthetics in the diabetic neuropathic nerve. In this rodent model of neuropathy, both pharmacodynamic and pharmacokinetic mechanisms contribute to prolonged nerve block duration.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Ten Hoope W, Hollmann MW, de Bruin K, et al. Pharmacodynamics and Pharmacokinetics of Lidocaine in a Rodent Model of Diabetic Neuropathy. Anesthesiology. 2018. PMID: 29251644. doi:10.1097/ALN.0000000000002035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。